BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 23378743)

  • 1. Patterns and predictors of antihypertensive medication used 1 year after ischemic stroke or TIA in urban China.
    Xu J; Ju Y; Wang C; Wang Y; Liu L; Zhao X; Wang C; Wang A; Wang Y
    Patient Prefer Adherence; 2013; 7():71-9. PubMed ID: 23378743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of secondary prevention medication and related factors for acute ischemic stroke and transient ischemic attack in China.
    Jiang Y; Yang X; Li Z; Pan Y; Wang Y; Wang Y; Ji R; Wang C
    Neurol Res; 2017 Jun; 39(6):492-497. PubMed ID: 28420316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Greater Adherence to Secondary Prevention Medications Improves Survival After Stroke or Transient Ischemic Attack: A Linked Registry Study.
    Dalli LL; Kim J; Cadilhac DA; Greenland M; Sanfilippo FM; Andrew NE; Thrift AG; Grimley R; Lindley RI; Sundararajan V; Crompton DE; Lannin NA; Anderson CS; Whiley L; Kilkenny MF
    Stroke; 2021 Nov; 52(11):3569-3577. PubMed ID: 34315251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihypertensive medications prescribed at discharge after an acute ischemic cerebrovascular event.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC
    Stroke; 2005 Sep; 36(9):1944-7. PubMed ID: 16051895
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Persistence of secondary prevention medications after acute ischemic stroke or transient ischemic attack in Chinese population: data from China National Stroke Registry.
    Ji R; Liu G; Shen H; Wang Y; Li H; Peterson E; Wang Y
    Neurol Res; 2013 Jan; 35(1):29-36. PubMed ID: 23317796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TOAST subtypes: its influence upon doctors' decisions of antihypertensive prescription at discharge for ischemic stroke patients.
    Xu J; Liu L; Wang Y; Zhao X; Wang C; Wang A; Wang Y
    Patient Prefer Adherence; 2012; 6():911-4. PubMed ID: 23269862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antihypertensive medication after ischemic stroke in young adults and its association with long-term outcome.
    van Dongen MME; Aarnio K; Martinez-Majander N; Pirinen J; Sinisalo J; Lehto M; Kaste M; Tatlisumak T; de Leeuw FE; Putaala J
    Ann Med; 2019 Feb; 51(1):68-77. PubMed ID: 30592437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Understanding of medications and associations with adherence, unmet needs, and perceived control of risk factors at two years post-stroke.
    Dalli LL; Andrew NE; Kim J; Cadilhac DA; Sanfilippo FM; Thrift AG; Nelson MR; Lannin NA; Olaiya MT; Ryan OF; Booth B; Gall S; Kilkenny MF;
    Res Social Adm Pharm; 2022 Sep; 18(9):3542-3549. PubMed ID: 35093283
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disparities in Antihypertensive Prescribing After Stroke: Linked Data From the Australian Stroke Clinical Registry.
    Dalli LL; Kim J; Thrift AG; Andrew NE; Lannin NA; Anderson CS; Grimley R; Katzenellenbogen JM; Boyd J; Lindley RI; Pollack M; Jude M; Durairaj R; Shah D; Cadilhac DA; Kilkenny MF
    Stroke; 2019 Dec; 50(12):3592-3599. PubMed ID: 31648630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prescription at discharge improves long-term adherence for secondary stroke prevention.
    Tsai JP; Rochon PA; Raptis S; Bronskill SE; Bell CM; Saposnik G
    J Stroke Cerebrovasc Dis; 2014 Oct; 23(9):2308-15. PubMed ID: 25149205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sociodemographic factors are associated with utilisation of statins after ischaemic stroke/TIA.
    Geary L; Aronius J; Wettermark B; Hasselström J; Sjöborg B; von Euler M
    Int J Clin Pract; 2017 Mar; 71(3-4):. PubMed ID: 28371022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recording a diagnosis of stroke, transient ischaemic attack or myocardial infarction in primary healthcare and the association with dispensation of secondary preventive medication: a registry-based prospective cohort study.
    Dahlgren C; Geary L; Hasselström J; Rehnberg C; Schenck-Gustafsson K; Wändell P; Euler MV
    BMJ Open; 2017 Sep; 7(9):e015723. PubMed ID: 28939569
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary prevention of stroke in Saskatchewan, Canada: hypertension control.
    Bartsch JA; Teare GF; Neufeld A; Hudema N; Muhajarine N
    Int J Stroke; 2013 Oct; 8 Suppl A100():32-8. PubMed ID: 23088414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Racial differences in persistence to secondary prevention medication regimens after ischemic stroke.
    Sheehan OC; Dhamoon MS; Bettger JP; Huang J; Liu C; Rhodes JD; Clay OJ; Roth DL
    Ethn Health; 2022 Oct; 27(7):1671-1683. PubMed ID: 34196573
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apparent Treatment-resistant Hypertension Among Individuals with History of Stroke or Transient Ischemic Attack.
    Howard VJ; Tanner RM; Anderson A; Irvin MR; Calhoun DA; Lackland DT; Oparil S; Muntner P
    Am J Med; 2015 Jul; 128(7):707-14.e2. PubMed ID: 25770032
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicines taken by older Australians after transient ischaemic attack or ischaemic stroke: a retrospective database study.
    Sluggett JK; Caughey GE; Ward MB; Gilbert AL
    Int J Clin Pharm; 2015 Oct; 37(5):782-9. PubMed ID: 25920907
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment with Multiple Therapeutic Classes of Medication Is Associated with Survival after Stroke.
    Kilkenny MF; Olaiya MT; Dalli LL; Kim J; Andrew NE; Sanfilippo FM; Thrift AG; Nelson M; Pearce C; Sanders L; Dewey H; Clissold B; Grimley R; Cadilhac DA
    Neuroepidemiology; 2022; 56(1):66-74. PubMed ID: 34758474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Secondary prevention after stroke/transient ischemic attack: A randomized audit and feedback trial.
    Geary L; Hasselström J; Carlsson AC; Eriksson I; von Euler M
    Acta Neurol Scand; 2019 Aug; 140(2):107-115. PubMed ID: 31017305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First hospitalization for transient ischemic attack in France: Characteristics, treatments and 3-year outcomes.
    Cosker K; Samson S; Fagot-Campagna A; Woimant F; Tuppin P
    Rev Neurol (Paris); 2016 Feb; 172(2):152-9. PubMed ID: 26318894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Secondary-prevention drug prescription in the very elderly after ischemic stroke or TIA.
    Ovbiagele B; Hills NK; Saver JL; Johnston SC
    Neurology; 2006 Feb; 66(3):313-8. PubMed ID: 16476928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.